Elicio Therapeutics Competitors and Similar CompaniesClear all
Elicio Therapeutics's competitors and similar companies include Arvinas.
 Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. |  Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations New Haven, US HQ |
Employees | Employees 22 | Employees 13329% increase |
Valuation ($) | Valuation ($) 47.5 m | Valuation ($) 1.9 b |
Financial | ||
Net income | Net income ($39.6m) (FY, 2025) | Net income ($80.8m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 150.3m | Total funding raised $ 111.6m |
For sources of this data, please see the company profile
View Company Profiles
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View company